Apimeds Pharmaceuticals US, Inc. (APUS): SCHEDULE 13D filed May 19, 2025

Name: Apimeds Pharmaceuticals US, Inc. SCHEDULE 13D (0001213900-25-045604)
Creator: Apimeds Pharmaceuticals US, Inc.
Published: 2025-05-19

Form type: SCHEDULE 13D
Filing date: May 19, 2025
Accession number: 0001213900-25-045604
Filer: Apimeds Pharmaceuticals US, Inc. (CIK 1894525)